Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Majestic Books, Hounslow, Regno Unito
EUR 68,05
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 66,33
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 68,85
Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 68,84
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 78,69
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
hardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Da: Revaluation Books, Exeter, Regno Unito
EUR 102,85
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 315 pages. 9.21x6.14x0.63 inches. In Stock.
EUR 68,02
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Sandeep Kumar, PhD, is a senior principal scientist at Pfizer, Inc. in the Biotherapeutics Pharmaceutical Sciences group, working on computational modeling and developability risk assessments of a wide variety of biotherapeutic drug cand.
Lingua: Inglese
Editore: Taylor & Francis Ltd Jun 2021, 2021
ISBN 10: 1032098201 ISBN 13: 9781032098203
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 84,17
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - This reference describes applications of computational and molecular modeling techniques toward more efficient and affordable biopharmaceutical drug development at the pre-clinical stages that could positively impact clinical outcomes. With a primary focus on the developability of monoclonal antibody candidates, it addresses many contributions t.
EUR 177,94
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 209,96
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 215,63
Quantità: 10 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
EUR 226,96
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 450.
EUR 241,30
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. pp. 450.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 239,53
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 249,56
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 450.
Da: Revaluation Books, Exeter, Regno Unito
EUR 316,69
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 297 pages. 8.00x5.00x1.00 inches. In Stock.
Da: moluna, Greven, Germania
EUR 179,01
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Sandeep Kumar, PhD, is a senior principal scientist at Pfizer, Inc. in the Biotherapeutics Pharmaceutical Sciences group, working on computational modeling and developability risk assessments of a wide variety of biotherapeutic drug cand.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 296,79
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, contributing to rising healthcare costs. Developability of Biotherapeutics: Computational Approaches describes applications of computational and molecular modeling techniques that improve the overall process of discovery and development by removing empiricism.The concept of developability involves making rational choices at the pre-clinical stages of biopharmaceutical drug development that could positively impact clinical outcomes. The book also addresses a general lack of awareness of the many different contributions that computation can make to biopharmaceutical drug development.This informative and practical reference is a valuable resource for professionals engaged in industrial research and development, scientists working with regulatory agencies, and pharmacy, medicine, and life science students and educators. It focuses primarily on the developability of monoclonal antibody candidates, but the principles described can also be extended to other modalities such as recombinant proteins, fusion proteins, antibody drug conjugates and vaccines.The book is organized into two sections. The first discusses principles and applications of computational approaches toward discovering and developing biopharmaceutical drugs. The second presents best practices in developability assessments of early-stage biopharmaceutical drug candidates.In addition to raising awareness of the promise of computational research, this book also discusses solutions required to improve the success rate of translating biologic drug candidates into products available in the clinic. As such, it is a rich source of information on current principles and practices as well as a starting point for finding innovative applications of computation towards biopharmaceutical drug development.